147 related articles for article (PubMed ID: 29325291)
1. [Hepatitis B core antigen promotes invasion of hepatocellular carcinoma cell line HepG2.2.15 via Toll-like receptor 4].
Hou HR; Kang Y; Li YK; Zeng YL; Wei JF; Ding GG; Peng Z; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):908-913. PubMed ID: 29325291
[No Abstract] [Full Text] [Related]
2. Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2.
Cheng S; Zhang B; Du JY; Jin YH; Lang HY; Zeng LH
Viral Immunol; 2017 Apr; 30(3):232-239. PubMed ID: 28061318
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
[TBL] [Abstract][Full Text] [Related]
4. A896G and C1196T Polymorphisms Within the TLR4 Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells.
Huang C; Zhang H; Bai R; Wang L; Lv J
DNA Cell Biol; 2017 Nov; 36(11):1029-1038. PubMed ID: 28945461
[TBL] [Abstract][Full Text] [Related]
5. TLR3 dsRNA agonist inhibits growth and invasion of HepG2.2.15 HCC cells.
Chen L; Xu YY; Zhou JM; Wu YY; E Q; Zhu YY
Oncol Rep; 2012 Jul; 28(1):200-6. PubMed ID: 22552584
[TBL] [Abstract][Full Text] [Related]
6. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.
Hsiao CC; Kao YH; Huang SC; Chuang JH
Pediatr Blood Cancer; 2013 Feb; 60(2):248-53. PubMed ID: 22648929
[TBL] [Abstract][Full Text] [Related]
8. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
[TBL] [Abstract][Full Text] [Related]
10. [Influence of celastrol on toll-like receptor 4-mediated signaling pathway in the free fatty acids-induced HepG2 cells].
Han LP; Sun B; Xie Y; Chen LM
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(32):2591-2596. PubMed ID: 30220146
[No Abstract] [Full Text] [Related]
11. Proteomics Based Identification of Autotaxin As An Anti-Hepatitis B Virus Factor and a Promoter of Hepatoma Cell Invasion and Migration.
She S; Yang M; Hu H; Hu P; Yang Y; Ren H
Cell Physiol Biochem; 2018; 45(2):744-760. PubMed ID: 29414802
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway.
Dong YQ; Lu CW; Zhang L; Yang J; Hameed W; Chen W
Mol Immunol; 2015 Dec; 68(2 Pt C):671-83. PubMed ID: 26589455
[TBL] [Abstract][Full Text] [Related]
13. The role of the toll-like receptor TLR4 in hepatitis B virus-associated glomerulonephritis.
Zhou Y; Zhu N; Wang X; Wang L; Gu LJ; Yuan WJ
Arch Virol; 2013 Feb; 158(2):425-33. PubMed ID: 23076739
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
[TBL] [Abstract][Full Text] [Related]
15. Effects of porcine MyD88 knockdown on the expression of TLR4 pathway-related genes and proinflammatory cytokines.
Dai C; Sun L; Yu L; Zhu G; Wu S; Bao W
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27707937
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
17. Modulation of hepatitis B surface antigen secretion by annexin II expressed in hepatitis B virus‑producing hepatoma cells.
Liu Y; Gao P
Mol Med Rep; 2014 Dec; 10(6):3113-7. PubMed ID: 25270731
[TBL] [Abstract][Full Text] [Related]
18. [Effect of IL-18 on peripheral blood monocytes from chronic hepatitis B patients].
Sun Y; Chen HY; Wang F; Zhang X; Jiang HQ; Shao FJ; Zhu SH
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):470-3. PubMed ID: 12939178
[TBL] [Abstract][Full Text] [Related]
19. The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B.
Wei XQ; Guo YW; Liu JJ; Wen ZF; Yang SJ; Yao JL
Clin Invest Med; 2008; 31(3):E123-30. PubMed ID: 18544275
[TBL] [Abstract][Full Text] [Related]
20. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
